Percutaneous Coronary Intervention
FDA designates recall of left-sided blood pumps as class I
Abiomed has issued a recall of the instructions for use for its left-sided blood pumps, as the pump catheter may perforate the wall of the left ventricle or cause free wall rupture, hypertension, lack of blood flow or death.
Troponin kinetics can be used to identify hemorrhagic MI, a dangerous condition after PCI
Hemorrhagic MI is associated with poor outcomes after PCI for STEMI and can be diagnosed via troponin kinetics, not necessarily requiring cardiac MRI, researchers reported at Cardiovascular Research Technologies.
Fewer women undergo revascularization for heart attack vs. men
Despite larger declines in STEMI and non-STEMI events from 2011 to 2018, women received proportionately fewer revascularization procedures and had a higher STEMI mortality rate vs. men, researchers reported.
‘Highly generalizable’ initiative lowers radiation exposure in Michigan cath labs
An initiative in Michigan successfully reduced patient, physician and staff exposure to procedural radiation during percutaneous coronary intervention, and may be generalizable in other states, researchers reported.
AI performs ‘exceptionally well’ predicting post-PCI outcomes
Researchers at University of Michigan Health developed an artificial intelligence model to accurately assess risk for post-procedural outcomes after PCI.
Intravascular imaging-guided PCI shows benefit for left main CAD vs. angiography
Intravascular imaging-guided PCI showed benefit vs. angiography for patients with left main CAD, with significantly lower risk for cardiac death or spontaneous target vessel-related MI, researchers reported.
PCI not cost-effective in patients with CAD, heart failure vs. optimal medical therapy
PHILADELPHIA — In patients with CAD and ischemic left ventricular dysfunction, PCI did not add significantly more quality-adjusted life-years and cost significantly more compared with optimal medical therapy alone, a speaker reported.
AI-enabled ECGs reduce time to cath lab in patients with suspected STEMI
PHILADELPHIA — An artificial intelligence-enabled ECG was associated with shorter time from ECG to catheterization laboratory entry in patients with suspected STEMI, according the results of the ARISE study.
VIDEO: Deepak L. Bhatt, MD, MPH, discusses gene editing, ORBITA-2, artificial intelligence
PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.
PCI improves angina symptoms vs. sham procedure in patients with stable CAD: ORBITA-2
PHILADELPHIA — In patients with stable angina and evidence of ischemia, PCI improved angina symptoms at 12 weeks compared with a sham procedure, according to the results from the ORBITA-2 trial.